JUST RELEASED Massachusetts Biopharma Industry Snapshot 2012 – Top 10 Highlights
Here are the top 10 highlights:
1. Industry Employment: 53, 253 – an all-time high. This accounts for over $6 billion in payroll.
2. Biotech R&D Jobs: Massachusetts leads the nation in R&D employment with over 28,000 positions in 2011.
3. Biotech R&D Industry Concentration: Massachusetts holds a dominant position in terms of industry concentration in “Biotechnology Research and Development” – almost twice the concentration of jobs as the next closest state:
4. Average Salary: $113,364, 89.9% higher than the estimated state average salary.
5. Venture Investment: $1.071 billion in Massachusetts biotechs – an all-time high. Massachusetts received a greater percentage of total VC investment than peers across the US.
6. VC Deals: TESARO, Agios, and Merrimack were among the top 10 biotech VC deals globally in 2011. TESARO and Merrimack both have since had IPOs in 2012.
7. Manufacturing: Massachusetts ran counter to the national declining trend, as one of only 5 of the leading biopharma manufacturing states that grew employment since 2002.
8. Drug Candidates: Massachusetts-headquartered companies have a total of 955 drug candidates at some stage of R&D. Oncology drug candidates make up 37% of that pipeline.
9. NIH Funded Hospitals: The top 5 NIH funded independent hospitals in the U.S. in 2011 are in Boston. Ten of the top 20 are in New England.
10. NIH Funding Per Capita: Massachusetts continues to far exceed other leading NIH-recipient states:
Compiled with support from EvaluatePharma
Read the full press release here.
See the full snapshot here.
Posted on September 13, 2012, in MassBio and tagged Biotech, Biotechnology Industry, EvaluatePharma, Industry Snapshot, Jobs, Massachusetts, National Institutes of Health, Pharmaceutical Industry, Venture Capital. Bookmark the permalink. 4 Comments.